TRACON Pharmaceuticals Inc (NASDAQ: TCON) closed the day trading at $0.26 down -2.67% from the previous closing price of $0.26. In other words, the price has decreased by -$0.0070 from its previous closing price. On the day, 1883063 shares were traded.
Ratios:
For a better understanding of TCON, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.16. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 0.89.
On February 10, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $24.
H.C. Wainwright reiterated its Buy rating for the stock on December 23, 2019, while the target price for the stock was revised from $15 to $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 27 ’23 when THEUER CHARLES bought 47,000 shares for $0.75 per share. The transaction valued at 35,250 led to the insider holds 399,417 shares of the business.
THEUER CHARLES bought 3,999 shares of TCON for $2,639 on Apr 26 ’23. The President and CEO now owns 352,417 shares after completing the transaction at $0.66 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TCON now has a Market Capitalization of 11.61M and an Enterprise Value of 3.28M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.96. Its current Enterprise Value per Revenue stands at 0.27 whereas that against EBITDA is 0.88.
Stock Price History:
Over the past 52 weeks, TCON has reached a high of $2.14, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 0.2690, while the 200-Day Moving Average is calculated to be 0.2350.
Shares Statistics:
Over the past 3-months, TCON traded about 3.36M shares per day on average, while over the past 10 days, TCON traded about 5.22M shares per day. A total of 44.27M shares are outstanding, with a floating share count of 40.26M. Insiders hold about 11.53% of the company’s shares, while institutions hold 11.02% stake in the company. Shares short for TCON as of Mar 15, 2024 were 1.9M with a Short Ratio of 0.57, compared to 856.28k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.17% and a Short% of Float of 4.21%.
Earnings Estimates
Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.06, while EPS last year was -$0.36. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.2 and -$0.26 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is -$0.16, with 2 analysts recommending between -$0.06 and -$0.27.
